Detalles de la búsqueda
1.
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry.
J Headache Pain;
24(1): 157, 2023 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37993795
Resultados
1 -
1
de 1
1
Próxima >
>>